 BOSTON, Jan. 04, 2022 GLOBE NEWSWIRE -- Aileron Therapeutics Nasdaq: ALRN, a chemoprotection oncology company focused on fundamentally transforming the experience of chemotherapy for cancer patients, is pleased to announce that Manuel Aivado, M.D., Ph.D., President and Chief Executive Officer, will provide a company overview and business update at the H.C. Wainwright BIOCONNECT Conference, which will be held virtually January 10th 12th and the Emerging Growth Conference, which will be held virtually on January 5th. Details of the upcoming Aileron presentations are as follows: 